Misplaced Pages

Milverine (drug): Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 15:48, 18 December 2024 editIdoghor Melody (talk | contribs)Autopatrolled, Event coordinators, Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers32,961 editsm clean upTag: AWB← Previous edit Revision as of 07:58, 19 December 2024 edit undoPygos (talk | contribs)Extended confirmed users, New page reviewers2,304 editsNo edit summaryTag: Visual editNext edit →
Line 58: Line 58:
| StdInChIKey = KMZHYAUKFHLFNY-UHFFFAOYSA-N | StdInChIKey = KMZHYAUKFHLFNY-UHFFFAOYSA-N
}} }}
'''Milverine''' is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.<ref>Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.</ref><ref>Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)</ref><ref>Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.</ref> '''Milverine''' is a ] (antispasmodic) agent that was developed in the latter half of the 20th century.<ref>Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.</ref><ref>Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)</ref><ref>Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.</ref>


The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.<ref>Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).</ref> The therapeutic use of fenpyramin as a ] and ] as well as ] and ] medicine was also identified.<ref>Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).</ref>


*Milverine is a bifunctional molecule; 1 half of the molecule contains ] and the other half of the molecule contains ]. Milverine is a bifunctional molecule; one half of the molecule contains ] and the other half of the molecule contains ].


==Synthesis== ==Synthesis==

Revision as of 07:58, 19 December 2024

Pharmaceutical compound
Milverine
Clinical data
Other namesFenprin, Fenpyramine, Miospasm.
Identifiers
IUPAC name
  • N-(3,3-diphenylpropyl)pyridin-4-amine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H20N2
Molar mass288.394 g·mol
3D model (JSmol)
SMILES
  • C1=CC=C(C=C1)C(CCNC2=CC=NC=C2)C3=CC=CC=C3
InChI
  • InChI=1S/C20H20N2/c1-3-7-17(8-4-1)20(18-9-5-2-6-10-18)13-16-22-19-11-14-21-15-12-19/h1-12,14-15,20H,13,16H2,(H,21,22)
  • Key:KMZHYAUKFHLFNY-UHFFFAOYSA-N

Milverine is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.

The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.

Milverine is a bifunctional molecule; one half of the molecule contains 3,3-Diphenylpropylamine and the other half of the molecule contains fampridine.

Synthesis

The chemical synthesis of milverine was identified.

Milverine synthesis
Milverine synthesis

Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively.

References

  1. Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.
  2. Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)
  3. Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.
  4. Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).
  5. Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).
Urologicals, including antispasmodics (G04B)
Acidifiers
Urinary antispasmodics
(primarily antimuscarinics)
Other urologicals
Irritable bowel syndrome (IBS)
Management
Related topics
Category: